Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans

Cell Reports

Volumn 15, Issue 5, 2016, Pages 1088-1099

  Liu, Lisa L ^a   Landskron, Johannes ^b   Ask, Eivind H ^b,c   Enqvist, Monika ^a   Sohlberg, Ebba ^a   Traherne, James A ^d   Hammer, Quirin ^e   Goodridge, Jodie P ^b,c   Larsson, Stella ^a   Jayaraman, Jyothi ^d   Oei, Vincent Y S ^b,c   Schaffer, Marie ^a   Taskén, Kjetil ^b,c   Ljunggren, Hans Gustaf ^a   Romagnani, Chiara ^e   Trowsdale, John ^d   Malmberg, Karl Johan ^a,b,c   Béziat, Vivien ^a,f,g  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^f IMAGINE INSTITUTE   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD2 ANTIGEN; HLA ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2C; S6 KINASE; UNCLASSIFIED DRUG; FC RECEPTOR; FCGR3B PROTEIN, HUMAN; GAMMA INTERFERON; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; KLRC2 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY C; PROTEIN S6;

ADAPTIVE IMMUNITY; ADULT; ANTIBODY RESPONSE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; CELL CULTURE; CYTOMEGALOVIRUS; DEFICIENCY; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM;

ADAPTIVE IMMUNITY; ANTIGENS, CD2; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOMEGALOVIRUS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GPI-LINKED PROTEINS; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; RECEPTORS, IGG; RIBOSOMAL PROTEIN S6;

EID: 84963954943     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.04.005     Document Type: Article

References (54)

1. Amir A.D., Davis K.L., Tadmor M.D., Simonds E.F., Levine J.H., Bendall S.C., Shenfeld D.K., Krishnaswamy S., Nolan G.P., Pe'er D. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat. Biotechnol. 2013, 31:545-552.
2. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002, 296:1323-1326.
3. Béziat V., Dalgard O., Asselah T., Halfon P., Bedossa P., Boudifa A., Hervier B., Theodorou I., Martinot M., Debré P., et al. CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur. J. Immunol. 2012, 42:447-457.
4. Béziat V., Liu L.L., Malmberg J.A., Ivarsson M.A., Sohlberg E., Björklund A.T., Retière C., Sverremark-Ekström E., Traherne J., Ljungman P., et al. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 2013, 121:2678-2688.
5. Béziat V., Traherne J., Malmberg J.-A., Ivarsson M.A., Björkström N.K., Retière C., Ljunggren H.-G., Michaëlsson J., Trowsdale J., Malmberg K.-J. Tracing dynamic expansion of human NK-cell subsets by high-resolution analysis of KIR repertoires and cellular differentiation. Eur. J. Immunol. 2014, 44:2192-2196.
6. Bryceson Y.T., March M.E., Ljunggren H.-G., Long E.O. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 2006, 107:159-166.
7. Crough T., Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin. Microbiol. Rev. 2009, 22:76-98.
8. Davis S.J., van der Merwe P.A. The structure and ligand interactions of CD2: implications for T-cell function. Immunol. Today 1996, 17:177-187.
9. Della Chiesa M., Falco M., Bertaina A., Muccio L., Alicata C., Frassoni F., Locatelli F., Moretta L., Moretta A. Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood. J. Immunol. 2014, 192:1471-1479.
10. Dong C., Davis R.J., Flavell R.A. MAP kinases in the immune response. Annu. Rev. Immunol. 2002, 20:55-72.
11. Enqvist M., Ask E.H., Forslund E., Carlsten M., Abrahamsen G., Béziat V., Andersson S., Schaffer M., Spurkland A., Bryceson Y., et al. Coordinated expression of DNAM-1 and LFA-1 in educated NK cells. J. Immunol. 2015, 194:4518-4527.
12. Foley B., Cooley S., Verneris M.R., Pitt M., Curtsinger J., Luo X., Lopez-Vergès S., Lanier L.L., Weisdorf D., Miller J.S. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood 2012, 119:2665-2674.
13. Forbes C.A., Scalzo A.A., Degli-Esposti M.A., Coudert J.D. Ly49C-dependent control of MCMV Infection by NK cells is cis-regulated by MHC Class I molecules. PLoS Pathog. 2014, 10:e1004161.
14. Goodier M.R., White M.J., Darboe A., Nielsen C.M., Goncalves A., Bottomley C., Moore S.E., Riley E.M. Rapid NK cell differentiation in a population with near-universal human cytomegalovirus infection is attenuated by NKG2C deletions. Blood 2014, 124:2213-2222.
15. Grier J.T., Forbes L.R., Monaco-Shawver L., Oshinsky J., Atkinson T.P., Moody C., Pandey R., Campbell K.S., Orange J.S. Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity. J. Clin. Invest. 2012, 122:3769-3780.
16. Gumá M., Angulo A., Vilches C., Gómez-Lozano N., Malats N., López-Botet M. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004, 104:3664-3671.
17. Hahn W.C., Bierer B.E. Separable portions of the CD2 cytoplasmic domain involved in signaling and ligand avidity regulation. J. Exp. Med. 1993, 178:1831-1836.
18. Jiang W., Johnson C., Jayaraman J., Simecek N., Noble J., Moffatt M.F., Cookson W.O., Trowsdale J., Traherne J.A. Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors. Genome Res. 2012, 22:1845-1854.
19. Jost S., Altfeld M. Control of human viral infections by natural killer cells. Annu. Rev. Immunol. 2013, 31:163-194.
20. Kaizuka Y., Douglass A.D., Vardhana S., Dustin M.L., Vale R.D. The coreceptor CD2 uses plasma membrane microdomains to transduce signals in T cells. J. Cell Biol. 2009, 185:521-534.
21. Kuijpers T.W., Baars P.A., Dantin C., van den Burg M., van Lier R.A.W., Roosnek E. Human NK cells can control CMV infection in the absence of T cells. Blood 2008, 112:914-915.
22. Lanier L.L. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 2008, 9:495-502.
23. Lanier L.L., Corliss B., Wu J., Phillips J.H. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 1998, 8:693-701.
24. Lazetic S., Chang C., Houchins J.P., Lanier L.L., Phillips J.H. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J. Immunol. 1996, 157:4741-4745.
25. Lee J., Zhang T., Hwang I., Kim A., Nitschke L., Kim M., Scott J.M., Kamimura Y., Lanier L.L., Kim S. Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals. Immunity 2015, 42:431-442.
26. Long E.O., Kim H.S., Liu D., Peterson M.E., Rajagopalan S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu. Rev. Immunol. 2013, 31:227-258.
27. +NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 2011, 108:14725-14732.
28. Luetke-Eversloh M., Hammer Q., Durek P., Nordström K., Gasparoni G., Pink M., Hamann A., Walter J., Chang H.-D., Dong J., Romagnani C. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog. 2014, 10:e1004441.
29. Manicklal S., Emery V.C., Lazzarotto T., Boppana S.B., Gupta R.K. The "silent" global burden of congenital cytomegalovirus. Clin. Microbiol. Rev. 2013, 26:86-102.
30. Marçais A., Cherfils-Vicini J., Viant C., Degouve S., Viel S., Fenis A., Rabilloud J., Mayol K., Tavares A., Bienvenu J., et al. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat. Immunol. 2014, 15:749-757.
31. Martinet L., Ferrari De Andrade L., Guillerey C., Lee J.S., Liu J., Souza-Fonseca-Guimaraes F., Hutchinson D.S., Kolesnik T.B., Nicholson S.E., Huntington N.D., Smyth M.J. DNAM-1 expression marks an alternative program of NK cell maturation. Cell Rep. 2015, 11:85-97.
32. McKinney E.F., Lee J.C., Jayne D.R.W., Lyons P.A., Smith K.G.C. T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature 2015, 523:612-616.
33. Miyashita R., Tsuchiya N., Hikami K., Kuroki K., Fukazawa T., Bijl M., Kallenberg C.G., Hashimoto H., Yabe T., Tokunaga K. Molecular genetic analyses of human NKG2C (KLRC2) gene deletion. Int. Immunol. 2004, 16:163-168.
34. Moingeon P., Lucich J.L., McConkey D.J., Letourneur F., Malissen B., Kochan J., Chang H.C., Rodewald H.R., Reinherz E.L. CD3 zeta dependence of the CD2 pathway of activation in T lymphocytes and natural killer cells. Proc. Natl. Acad. Sci. USA 1992, 89:1492-1496.
35. Moraru M., Cañizares M., Muntasell A., de Pablo R., López-Botet M., Vilches C. Assessment of copy-number variation in the NKG2C receptor gene in a single-tube and characterization of a reference cell panel, using standard polymerase chain reaction. Tissue Antigens 2012, 80:184-187.
36. Moraru M., Cisneros E., Gómez-Lozano N., de Pablo R., Portero F., Cañizares M., Vaquero M., Roustán G., Millán I., López-Botet M., Vilches C. Host genetic factors in susceptibility to herpes simplex type 1 virus infection: contribution of polymorphic genes at the interface of innate and adaptive immunity. J. Immunol. 2012, 188:4412-4420.
37. Nabekura T., Kanaya M., Shibuya A., Fu G., Gascoigne N.R.J., Lanier L.L. Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection. Immunity 2014, 40:225-234.
38. Noyola D.E., Fortuny C., Muntasell A., Noguera-Julian A., Muñoz-Almagro C., Alarcón A., Juncosa T., Moraru M., Vilches C., López-Botet M. Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children. Eur. J. Immunol. 2012, 42:3256-3266.
39. Orbelyan G.A., Tang F., Sally B., Solus J., Meresse B., Ciszewski C., Grenier J.-C., Barreiro L.B., Lanier L.L., Jabri B. Human NKG2E is expressed and forms an intracytoplasmic complex with CD94 and DAP12. J. Immunol. 2014, 193:610-616.
40. Parham P., Moffett A. Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat. Rev. Immunol. 2013, 13:133-144.
41. Pollizzi K.N., Powell J.D. Integrating canonical and metabolic signalling programmes in the regulation of T cell responses. Nat. Rev. Immunol. 2014, 14:435-446.
42. Pyzik M., Dumaine A., Charbonneau B., Fodil-Cornu N., Jonjic S., Vidal S.M. Viral MHC class I-like molecule allows evasion of NK cell effector responses in vivo. J. Immunol. 2014, 193:6061-6069.
43. Revello M.G., Gerna G. Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications. Rev. Med. Virol. 2010, 20:136-155.
44. Schlums H., Cichocki F., Tesi B., Theorell J., Beziat V., Holmes T.D., Han H., Chiang S.C.C., Foley B., Mattsson K., et al. Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity 2015, 42:443-456.
45. Smith M.E., Thomas J.A. Cellular expression of lymphocyte function associated antigens and the intercellular adhesion molecule-1 in normal tissue. J. Clin. Pathol. 1990, 43:893-900.
46. Smith-Garvin J.E., Koretzky G.A., Jordan M.S. T cell activation. Annu. Rev. Immunol. 2009, 27:591-619.
47. Sun J.C., Beilke J.N., Lanier L.L. Adaptive immune features of natural killer cells. Nature 2009, 457:557-561.
48. Sylwester A.W., Mitchell B.L., Edgar J.B., Taormina C., Pelte C., Ruchti F., Sleath P.R., Grabstein K.H., Hosken N.A., Kern F., et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 2005, 202:673-685.
49. Tandon R., Mocarski E.S. Viral and host control of cytomegalovirus maturation. Trends Microbiol. 2012, 20:392-401.
50. Thomas R., Low H.Z., Kniesch K., Jacobs R., Schmidt R.E., Witte T. NKG2C deletion is a risk factor of HIV infection. AIDS Res. Hum. Retroviruses 2012, 28:844-851.
51. van Lier R.A.W., ten Berge I.J.M., Gamadia L.E. Human CD8(+) T-cell differentiation in response to viruses. Nat. Rev. Immunol. 2003, 3:931-939.
52. Vivier E., Morin P.M., O'Brien C., Schlossman S.F., Anderson P. CD2 is functionally linked to the zeta-natural killer receptor complex. Eur. J. Immunol. 1991, 21:1077-1080.
53. Vivier E., Raulet D.H., Moretta A., Caligiuri M.A., Zitvogel L., Lanier L.L., Yokoyama W.M., Ugolini S. Innate or adaptive immunity? The example of natural killer cells. Science 2011, 331:44-49.
54. Zhang T., Scott J.M., Hwang I., Kim S. Cutting edge: antibody-dependent memory-like NK cells distinguished by FcRγ deficiency. J. Immunol. 2013, 190:1402-1406.